William H Garner Iii, MD | |
2100 Market Street, Charlestown, IN 47111 | |
(812) 256-7830 | |
(812) 256-7835 |
Full Name | William H Garner Iii |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 2100 Market Street, Charlestown, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366585572 | NPI | - | NPPES |
000000042422 | Other | IN | ANTHEM MEDICAID |
021760854 | Other | IN | RAILROAD MEDICARE |
100138490 | Other | IN | MDWISE HOOSIER ALLIANCE |
000000042422 | Other | IN | ANTHEM |
100138490 | Other | IN | MANAGED HEALTH SERVICES |
000000042422 | Other | IN | INDIANA COMPREHENSIVE |
100138490 | Medicaid | IN | |
000000042422 | Other | IN | HEALTHLINK |
000000042422 | Other | KY | ANTHEM |
242150B | Other | IN | UNICARE MEDICARE |
000000042422 | Other | IN | ONE NATION BENEFIT |
000000042422 | Other | IN | UNICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 01031544 (Indiana) | Secondary |
208600000X | Surgery | 01031544A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
William H Garner Iii, MD 2100 Market Street, Charlestown, IN 47111 Ph: (812) 256-7442 | William H Garner Iii, MD 2100 Market Street, Charlestown, IN 47111 Ph: (812) 256-7830 |
News Archive
Neurosurgeons from NYU Langone Medical Center will present research and discuss surgical approaches and use of new technologies to treat neurosurgical conditions at the annual meeting of the American Association of Neurological Surgeons (AANS), held April 14-18, 2012 in Miami Beach, FL.
As the nights grow longer and winter settles in across the north, a team of health researchers is using a "community mobilization" approach to translate research into practice for an Alaska Native youth suicide prevention program in 15 remote Alaska towns.
In a new bioRxiv* preprint paper, researchers from the Imperial College London, King's College London, and the University of Bristol in the United Kingdom show that the furin cleavage site of SARS-CoV-2 spike glycoprotein represents a key determinant for transmission among humans, as it substantially facilitates replication in airway cells - opening the door for the development of novel therapeutics.
A landmark study on how cannabis affects driving ability has shown that cannabidiol (CBD), a cannabis component now widely used for medical purposes, does not impair driving, while moderate amounts of the main intoxicating component tetrahydrocannabinol (THC) produce mild driving impairment lasting up to four hours.
› Verified 2 days ago